Quick takes: Novavax COVID vaccine effectiveness, COVID booster uptake, avian flu in two states By iopac on October 6, 2023 Over a 4-month period, protection with the Novavax vaccine was stable against symptomatic COVID infection. Published in COVID-19 iopac More from COVID-19More posts in COVID-19 »COVID booster linked to 25% lower odds of long COVIDAfter COVID vaccine rollout, negativity on Twitter spikedX’s crowdsourced tool to counter COVID untruths mainly accurate, credible, researchers sayWHO COVID vaccine advisers recommend switch to JN.1 strain